WHO’s classification of hepatitis D virus as carcinogenic raises urgent questions for vaccination, screening, and treatment strategies worldwide.

One patient has glioblastoma multiforme (GBM), and the other patient has advanced hepatocellular carcinoma (HCC) treated in the second line. Neither patient has experienced PIC-related adverse events ...

Early on-treatment LSM accurately predicts liver-related events in chronic hepatitis B with significant fibrosis and cirrhosis. Liver-related event (LRE) risk is better predicted by liver stiffness ...

Alida Biosciences’ EpiPlex platform uses robust assay controls and specialized bioinformatics to detect RNA modification, genomic coordinates, and relative quantity.

REDWOOD CITY, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (NASDAQ: CHRS), today announced an upcoming poster presentation at the 40th Annual Meeting of the Society for ...

NEW HAVEN, Conn. (WTNH) — In today’s Health Headlines, October is Liver Cancer Awareness Month, an important time to highlight the challenges and progress in combating one of the fastest-growing ...

Biochemical non-response to obeticholic acid as a second-line therapy predicted a heightened risk for clinical events in patients with primary biliary cholangitis (PBC). Although response rates to ...

A diagnosis of kidney cancer, also known as renal cancer, requires strong partnership with your oncologist. This overview is designed to provide you with fundamental knowledge about Stage 2 disease, ...

This important study identifies a putative iron and zinc transporter in the plasma membrane of the obligate intracellular pathogen, Toxoplasma gondii. Using an array of different approaches, the ...

Early-onset hypertension during treatment with atezolizumab and bevacizumab is a favorable prognostic marker in unresectable HCC. The combination of atezolizumab and bevacizumab has emerged as a ...